Dividend King Growth Giant: J&J Faces Lilly Challenge
Johnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Simplify your finances with user-friendly finance management tools. These resources will help you stay organized and in control of your money.
22,305 articlesJohnson & Johnson and Eli Lilly reported contrasting Q1 2026 results, pitting a durable, dividend-focused giant again...
Gold continues its 2026 rally as inflation stays stubborn. Three bullion ETFs offer differing cost paths to own alloc...
BTC briefly climbed to $64,000 before stumbling, while Pi Network’s PI token nears a new all-time low. Traders eye ma...
Backlog in the commercial space economy just reached a pivotal $500 billion mark as SpaceX began trading on NASDAQ, s...
MTUM has surged on momentum bets early in July, but a rotation out of high-multiple growth could weigh on the fund. T...
As Trump renews calls to reshape the Fed, Wall Street remains inclined toward higher rates by year-end, backed by res...
AMD's quarterly results show data-center strength lifting the growth story. This piece maps a 5-year prediction stock...
SpaceX has joined the Nasdaq 100, triggering a wave of expected passive buying estimated at $27 billion as lockups un...
A retiring CFO faces a pivotal decision: take a lump-sum payout from a long‑standing nonqualified deferred compensati...
Fiserv announced the resignation of fiserv president dhivya suryadevara after less than a month in the role, with int...
The memory market has been on a wild ride. After sharp gains earlier this year, Micron and SanDisk pulled back, promp...
Set a weekly ritual to translate headlines into a smarter portfolio. This Thursday reads guide shows you how to pick ...